Del Monte Pacific (D03) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
11 Mar, 2026Executive summary
Achieved strong growth in Q3 and nine months ended January 2026, with sales up 20% in Q3 and 14.2% year-to-date, driven by robust performance in the Philippines and international markets.
Net profit reached $10 million in Q3 (up from $2.5 million) and $32.3 million year-to-date (up from $5.2 million), reflecting improved sales and margins.
Deconsolidation of U.S. operations effective 1 May 2025, following Chapter 11 filing, reduced liabilities and shifted focus to core Asian businesses.
Strategic focus remains on expanding Asian operations, market leadership in the Philippines, and regaining or maintaining international market share, especially in premium pineapples.
Ongoing capital-raising initiatives and divestment of non-core assets to address negative equity and optimize capital allocation.
Financial highlights
Q3 sales: $243.8 million, up 20% year-over-year; nine-month revenue: $682.4 million, up 14.2%.
Gross margin improved to 32.7% in Q3 and 33.2% year-to-date, supported by pricing, sales mix, and commodity trends.
EBITDA for nine months: $133.5 million, up 22.8%; Q3 EBITDA: $42.8 million (+16.2%).
Net profit attributable to owners was $10 million in Q3 (up 300.5%) and $32.3 million for nine months (up 526.4%).
Net debt reduced to $990 million, with net debt/EBITDA improving to 5.9x from 7.5x.
Outlook and guidance
Profitability expected to be sustained for FY2026, barring unforeseen circumstances and with no material liability from U.S. operations post-deconsolidation.
Continued focus on equity raise to support financial health, reduce leverage, and address capital deficit.
Anticipate continued growth in processed and fresh segments, with caution due to potential geopolitical and economic volatility.
Latest events from Del Monte Pacific
- Net profit surged 192.6% on 9% higher sales, with restructuring underway to address negative equity.D03
Q1 2027 - Strong FY2026 growth and profitability, but negative equity restricts dividends.D03
Q4 2026 - Q2 sales rose 9.9% and net profit more than sevenfold, led by Asian markets and fresh exports.D03
Q2 2026 - Sales and margins rose, net profit reached US$5.5M; FY2026 profitability is expected.D03
Q1 2026 - Asian operations returned to profit after U.S. deconsolidation and impairment.D03
Q4 2025 - Sales up 4% but net loss widened to US$56m on higher costs and U.S. subsidiary challenges.D03
Q2 2025 - Sales up 4% year-over-year; net loss widened on US costs, but margin and turnaround efforts continue.D03
Q1 2025 - Net loss widened to $127m on flat sales; margin recovery and asset sales targeted in FY25.D03
Q4 2024 - Sales rose, but DMFC losses outweighed DMPI growth and widened the group loss.D03
Q3 2025